辉瑞新冠疫苗接种后获得性血栓性血小板减少性紫癜
Acquired thrombotic thrombocytopenic purpura following Pfizer COVID-19 vaccination.
作者信息
Alislambouli Mawaddah, Veras Victoria Andy, Matta Jyoti, Yin Faye
机构信息
Department of Medicine Jersey City Medical Center Jersey City New Jersey USA.
出版信息
EJHaem. 2021 Nov 16;3(1):207-210. doi: 10.1002/jha2.342. eCollection 2022 Feb.
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare disease and has occasionally been described after vaccination, especially against viral agents. We present a case of a patient who presents with the classic pentad of TTP a few days after receiving the first dose of the mRNA Pfizer COVID-19 vaccine. To our knowledge, this is the second report of a de novo TTP following mRNA Pfizer COVID-19 vaccination.
获得性血栓性血小板减少性紫癜（aTTP）是一种罕见疾病，在接种疫苗后偶有报道，尤其是针对病毒制剂的疫苗。我们报告一例患者，在接种第一剂辉瑞mRNA新冠疫苗几天后出现了典型的血栓性血小板减少性紫癜五联征。据我们所知，这是第二例接种辉瑞mRNA新冠疫苗后新发血栓性血小板减少性紫癜的报告。
Zotero 插件